P - Present
Roll Call
OTHERS PRESENT: See Original Minutes
The meeting was called to order by Representative Cutler, Chair
MOTION:
TO APPROVE THE MINUTES OF JANUARY 19, 2007
E - Excused
A - Absent
P Buckingham
P Engels
P Feinstein
P Gillespie
P Gilson
P Hunt, Vice-Chair
P Lust
P Moore
P Peters
P Vanneman
P Vehle
P Willadsen
P Cutler, Chair
Moved by: Hunt
Second by: Willadsen
Action: Prevailed by voice vote.
HB 1085: revise certain provisions related to the transfer of title.
Presented by: Representative Joel Dykstra
Proponents: Roger Tellinghuisen, SD County Officials Association
MOTION:
DO PASS HB 1085
Moved by: Hunt
Second by: Peters
Action: Prevailed by roll call vote.(12-0-1-0)
Voting Yes: Buckingham, Engels, Feinstein, Gilson, Hunt, Lust, Moore, Peters, Vanneman,
Vehle, Willadsen, Cutler
Excused: Gillespie
MOTION:
PLACE HB 1085 ON CONSENT CALENDAR
Moved by: Vehle
Second by: Peters
Action: Prevailed by voice vote.
HB 1071: revise certain provisions regarding the title of initiated measures and the
filing of initiated measures.
Presented by: Rich Williams, Office of Attorney General
Proponents: Chad Heinrich, Deputy Secretary of State
MOTION:
DO PASS HB 1071
Moved by: Moore
Second by: Engels
Action: Prevailed by roll call vote.(13-0-0-0)
Voting Yes: Buckingham, Engels, Feinstein, Gillespie, Gilson, Hunt, Lust, Moore, Peters,
Vanneman, Vehle, Willadsen, Cutler
HB 1073: revise certain provisions regarding identification and recording for
products containing pseudoephedrine or ephedrine.
Presented by: Rich Williams, Office of Attorney General
Proponents: Sue Schaefer, SD Pharmacists
Shawn Lyons, SD Retailers Association
MOTION:
AMEND HB 1073
Moved by: Hunt
Second by: Gillespie
Action: Prevailed by voice vote.
MOTION:
AMEND HB 1073
"
Section 1. That
§
34-20D-1
be repealed.
34-20D-1.
No retailer may sell, in a single transaction, more than two packages containing
pseudoephedrine or ephedrine as an active ingredient. For purposes of this chapter, the term, retailer,
means any person who sells merchandise at retail and from whom original packages of
nonprescription drugs are sold or taken to be sold at retail and who is licensed by the Board of
Pharmacy to sell nonprescription drugs. This restriction does not apply to any sale made pursuant
to a valid prescription drug order prescribed by a practitioner as defined in § 36-11-2 with
appropriate authority. Any retailer or any employee of a retailer who sells packages containing
pseudoephedrine or ephedrine in violation of this section is guilty of a Class 1 misdemeanor.
Section 2. That
§
34-20D-2
be repealed.
34-20D-2.
No person may purchase, in a single transaction, more than two packages containing
pseudoephedrine or ephedrine as an active ingredient. This restriction does not apply to purchases
made with a valid prescription drug order prescribed by a practitioner as defined in § 36-11-2 with
appropriate authority. Any person who purchases packages containing pseudoephedrine or ephedrine
in violation of this section is guilty of a Class 1 misdemeanor.
Section 3. That
§
34-20D-3
be repealed.
34-20D-3.
Any retailer who offers for sale a product containing pseudoephedrine or ephedrine
as an active ingredient shall display and offer the product for sale, except as otherwise provided,
behind a counter where the public is not permitted or in a locked case so that a customer wanting
access to the package must ask a store employee for assistance. The retailer may display or offer for
sale without restriction a product containing pseudoephedrine or ephedrine as an active ingredient
if the product is displayed using any type of anti-theft device system including an electronic anti-theft
device system that utilizes a product tag and detection alarm which prevents the theft of the product.
Section 4. That § 34-20D-5 be repealed.
Section 5. That
§
34-20D-6
be repealed.
34-20D-6.
No employee or retailer is civilly liable to any injured person or the person's estate for
any injury suffered, including any wrongful death, or property damage suffered due to the sale of any
pseudoephedrine or ephedrine product in violation of § 34-20D-1.
Section 6. That
§
34-20D-7
be repealed.
34-20D-7.
No county or municipality may establish requirements or establish a penalty that is
higher or more stringent than the requirements or penalties established by this chapter.
Section 7. That
§
34-20D-8
be repealed.
34-20D-8.
If offering for sale a product containing pseudoephedrine or ephedrine as an active
ingredient, a retailer shall, before making such a sale, require and make a record of the identification
of the person purchasing the product containing pseudoephedrine or ephedrine. For purposes of this
section, the term, identification, means a document issued by a governmental agency which contains
a description of the person or a photograph of the person, or both, and gives the person's date of
birth, such as a driver's license, passport, or military identification card. The retailer shall maintain
the record of identification, including the purchaser's name and date of birth. On August 1, 2006, and
no later than the fifth day of every month thereafter, the retailer shall send any such records to the
Office of the Attorney General. No retailer may use or maintain the record for any private or
commercial purpose or disclose the record to any person, except as authorized by law. The retailer
shall disclose the record, upon request, to a law enforcement agency for a law enforcement purpose.
Section 8. That
§
34-20D-9
be repealed.
34-20D-9.
Any retailer who in good faith releases information governed by this chapter to a law
enforcement agency for a law enforcement purpose is immune from civil liability for such release
unless the release constitutes gross negligence or intentional, wanton, or willful misconduct.
"
Moved by: Peters
Second by: Engels
Carolyn Jorgensen